Home » Topics » BioWorld Science

BioWorld Science
RSS

First patients dosed in new studies of Xpovio in melanoma and myelofibrosis

July 29, 2021

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent PD-1/PD-L1 inhibitors

July 29, 2021

New RORgammaT agonists identified at Sunshine Lake Pharma

July 29, 2021

Chengdu Baiyu Pharmaceutical presents new tetrahydrocannabinol derivatives

July 29, 2021

DiosCURE enters licensing agreement for single-domain antibodies against SARS-CoV-2

July 28, 2021

Eccogene begins first-in-human study of ECC-0509 for NASH and osteoarthritis pain

July 28, 2021

University of Oxford tests vaccine against plague in phase I

July 28, 2021

Ipsen and BAKX Therapeutics partner on BKX-001

July 28, 2021

Mouse model shows targeting RagC GTPase could safely treat B-cell lymphomas

July 28, 2021

Dosing underway in phase I trial of AR degrader GT-20029 in China

July 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...